Sinopsis

It approaches obesity from a multidimensional perspective, combining methodologies of biomarkers, imaging, body composition, and functionality, both of fat mass and muscle mass.
It offers in-depth reflection, knowledge, vision, and tools to successfully address the CMAD underlying the chronic pathologies that are encountered in daily clinical practice.
It aims to optimize the methodology, define cutoff points, incorporate evidence into clinical practice guidelines, establish treatment outcomes, and their relationship to morbidity and mortality.

Currently, we understand obesity as a pathological state caused by an excess of body fat, which underestimates the multidimensionality of the problem. The concept of Chronic Metabolic Adipose Disease (CMAD) better addresses the need to define obesity as a complex, heterogeneous, chronic disease that varies in its pathophysiology, progression, and response to the different therapeutic strategies used.

Índice

SECTION I. General Concepts of Chronic Metabolic Disease

Overview of chronic metabolic adipose disease: from physiology to clinic
Chronic metabolic adipose disease. Adipose tissue: the YIN?
Chronic Metabolic Adipose Disease. Muscle: the YANG?
Diagnosis, assessment, phenotypes, and distribution patterns of chronic metabolic adipose disease
Biochemical markers of adipose dysfunction
Adiposity and its distribution patterns in precision medicine applied to type 2 diabetes
Clinical scales of chronic metabolic adipose disease

SECTION II. Techniques Used

Anthropometry and chronic metabolic adipose disease
BIA and phase angle in chronic metabolic adipose disease
Nutritional ultrasound® in chronic metabolic adipose disease
Other reference morphological techniques (DXA, CT, MRI) in chronic metabolic adipose disease. New imaging and adipose tissue definitions
Morphofunctional Assessment in Chronic Metabolic Adipose Disease
Muscle function tests in chronic metabolic adipose disease
Hand dynamometry applied to chronic metabolic adipose disease
Methodology in morphofunctional research applied to chronic metabolic adipose disease

SECTION III. Clinical Assessment

Morphofunctional assessment of chronic metabolic adipose disease and diabetes
Morphofunctional assessment in nephropathy secondary to chronic metabolic adipose disease
Morphofunctional assessment in sarcopenic obesity
Morphofunctional assessment in hepatic chronic metabolic adipose disease
Morphofunctional assessment in respiratory pathology associated with chronic metabolic adipose disease
Morphofunctional assessment of dyslipidemia in chronic metabolic adipose disease
Morphofunctional assessment in chronic metabolic adipose disease associated with type 1 diabetes
Morphofunctional assessment in chronic metabolic adipose disease in gynecologic pathology
Morphofunctional assessment monitoring (MFAM) in chronic metabolic adipose disease